Literature DB >> 15503306

Neovascularization of bone marrow in patients with diffuse multiple myeloma: a correlative study of magnetic resonance imaging and histopathologic findings.

Andrea Baur1, Reiner Bartl, Christoph Pellengahr, Vivian Baltin, Maximilian Reiser.   

Abstract

BACKGROUND: The goal of the current study was to assess the correlation between bone marrow histology and contrast enhancement in infiltrative diffuse myeloma.
METHODS: Forty-four patients with homogeneous diffuse infiltration of bone marrow by multiple myeloma were examined using magnetic resonance imaging of the spine. The sequence protocol included T1-weighted spin-echo (pre- and post-gadolinium dimeglumine administration) and short-inversion time inversion recovery sequences. The percent increase in signal after intravenous gadolinium administration was calculated in bone marrow from patients with myeloma and from a control group of 86 patients who did not have bone marrow disease. Grade of infiltration with plasma cells, fat cell content, and hematopoietic marrow content were evaluated via histologic assessment of bone marrow, and microvessel density was evaluated via anti-CD34-positive immunostaining.
RESULTS: Increased microvessel density was observed in association with increasing plasma cell content (Kruskall-Wallis test: P < 0.0001). Contrast enhancement increased in a stepwise manner according to grade of microvessel density (Mann-Whitney U test: P < 0.05 and P < 0.001 for increases from low to intermediate and intermediate to high grade) and was significantly higher in patients with myeloma compared with control patients (Mann-Whitney U test: P < 0.001). A significant correlation also was found between histologic extent of tumor infiltration and contrast enhancement (Mann-Whitney U test: P < 0.0001). The mean level of contrast enhancement was 18% in the control group, 26% in patients with low-grade infiltration, 49% in patients with intermediate-grade infiltration, and 90% in patients with high-grade infiltration. In addition, fat cell content was found to be inversely correlated with contrast enhancement (chi-square test: P < 0.01).
CONCLUSIONS: As a consequence of increased microvessel density, decreased fat cell content, and increased cellularity, the presence of diffuse bone marrow infiltration in patients with multiple myeloma can be verified using gadolinium-enhanced magnetic resonance imaging. (c) 2004 American Cancer Society

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15503306     DOI: 10.1002/cncr.20697

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

Review 1.  Total-body MR-imaging in oncology.

Authors:  Juergen F Schaefer; Heinz-Peter W Schlemmer
Journal:  Eur Radiol       Date:  2006-04-19       Impact factor: 5.315

Review 2.  The evolving role of MRI in oncohaematological disorders.

Authors:  O Tamburrini; M A Cova; D Console; P Martingano
Journal:  Radiol Med       Date:  2007-07-24       Impact factor: 3.469

Review 3.  Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma.

Authors:  Julie C Dutoit; Koenraad L Verstraete
Journal:  Skeletal Radiol       Date:  2017-03-13       Impact factor: 2.199

4.  Differentiation of myeloma and metastatic cancer in the spine using dynamic contrast-enhanced MRI.

Authors:  Ning Lang; Min-Ying Su; Hon J Yu; Muqing Lin; Mark J Hamamura; Huishu Yuan
Journal:  Magn Reson Imaging       Date:  2013-01-03       Impact factor: 2.546

5.  Dynamic contrast enhanced magnetic resonance imaging of diffuse spinal bone marrow infiltration in patients with hematological malignancies.

Authors:  Yunfei Zha; Maojin Li; Jianyong Yang
Journal:  Korean J Radiol       Date:  2010-02-22       Impact factor: 3.500

Review 6.  MRI in multiple myeloma: a pictorial review of diagnostic and post-treatment findings.

Authors:  Julie C Dutoit; Koenraad L Verstraete
Journal:  Insights Imaging       Date:  2016-05-10

Review 7.  Whole body MRI and PET/CT in haematological malignancies.

Authors:  Chieh Lin; Alain Luciani; Emmanuel Itti; Corinne Haioun; Alain Rahmouni
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

Review 8.  Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma.

Authors:  Susanne Lütje; Jacky W J de Rooy; Sandra Croockewit; Emmeline Koedam; Wim J G Oyen; Reinier A Raymakers
Journal:  Ann Hematol       Date:  2009-12       Impact factor: 3.673

9.  Quantitative whole-body MR imaging for assessment of tumor burden in patients with multiple myeloma: correlation with prognostic biomarkers.

Authors:  Mengtian Sun; Jingliang Cheng; Cuiping Ren; Yong Zhang; Yinhua Li; Ying Li; Suping Zhang
Journal:  Quant Imaging Med Surg       Date:  2021-08

10.  Osteocyte Vegf-a contributes to myeloma-associated angiogenesis and is regulated by Fgf23.

Authors:  Patrick L Mulcrone; Shanique K E Edwards; Daniela N Petrusca; Laura S Haneline; Jesús Delgado-Calle; G David Roodman
Journal:  Sci Rep       Date:  2020-10-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.